Related
They're certainly making it harder for J&J to come back. Strategically we believe Boston Scientific ...
JOANNE WUENSCH We suspect the new Boston Scientific offer was developed with input from the Guidant board, so it's ...
LARRY BIEGELSEN If J&J is not willing to up their bid, I think Guidant will be going to Boston Scientific.
DEBBIE WANG At this point, we do not know if J&J is simply trying to force Boston Scientific to go higher, or if...
BOB HOPKINS Today's outcome is a tremendous victory and a major milestone within the merger process, ... It is c...
KEN THOMPSON I would try to settle all the outstanding liability claims at this point in time, so that it doesn't...
ALLEN MICHEL I don't believe these things are going to matter for Boston Scientific. This is a strategic deal for...
JAN WALD This is disappointing, as we believe the logic for combining the two businesses is compelling.
LORNA TILBIAN In our opinion, the strategic rationale is sound and price paid is lower than what we would have ant...
MORGAN STANLEY It's very clear Boston Scientific is not making this acquisition for what this company can do in 200...
FRANK AQUILA Q4 is behind us, and what the Boston Scientific investment thesis is now is the future, and particul...
THOMAS GUNDERSON Lingering concerns about an inventory correction simply have not been borne out.
DANIEL HEYLER We have brought a lot of companies into the Boston Scientific family and we have never been more con...
PAUL DONOVAN I think Boston Scientific and ANSI have the better technology now, especially with the rechargeable.
JEFF JONAS I think Boston Scientific and ANSI have the better technology now, especially with the rechargeable,
JEFF JONAS We see no compelling scientific reason to re-create the virulent virus.
EDWARD HAMMOND We believe the transaction and the strategic rationale for this combination are in the best interest...
JAMES CORNELIUS If the deals went to shareholders today, we believe Boston Scientific would prevail.
MARK LANDY We feel that by combining Red Hat's strengths in servers and workstation technology with Cygnus' exp...
ERIK TROAN![]()
What the Commission is seeking cuts the heart out of the strategic rationale of our deal,
JACK WELCH Myths about the dire effects of genetically modified foods on health and the environment abound, but...
NINA FEDOROFF Underneath the covers I believe that Abbott wants to be a device player and for the first time they ...
RYAN RAUCH It's a slam-dunk for Boston Scientific, and I think there are implications for the rest of the indus...
DHULSINI DE ZOYSA I don't see material upside or downside (for Boston Scientific shares) for the next 12 months.
MARK LANDY We see a very compelling strategic fit and see our combined companies strongly positioned to compete...
LARRY GLASSCOCK We doubt this show is over, and in the end we expect that Boston Scientific will increase its bid.
JOANNE WUENSCH I like to open for a band as it brings on sort of a challenge and it makes things more interesting. ...
KELLY JONES We ask that you declare any subsequent offer with improved terms from Boston Scientific as superior.
IVAN KRSTICEVIC One of the most compelling findings is that AAV-2 appears to have no pathologic effects on healthy c...
CRAIG MEYERS FEMA is aware of local concerns where sites are proposed, and balances those concerns with its urgen...
SCOTT WELLS We believe that Boston Scientific can raise its offer to $78 a share and still maintain an investmen...
LARRY BIEGELSEN We believe this compelling valuation offsets very real concerns about management's ability to develo...
CHRISTOPHER DIXON Boston Scientific wants as many shots on goal as they can get.
DANIEL OWCZARSKI There are compelling advantages to combining these operations. It allows us to leverage the strength...
GARY RODKIN There is no compelling reason today for these businesses to remain together. Almost every strategic ...
BRUCE WASSERSTEIN Despite the efficacy advantage, CAIV-T will have to overcome its premium pricing and lingering safet...
JAMES REDDOCH Boston Scientific still has much 'wood to chop' regarding the recovery of the company's cardiac rhyt...
GLENN REICIN Combining premier aviation choices and luxury destinations is a win-win for both of our companies. W...
KEN AUSTIN In our view, Abbott is the clear winner in this deal.
LARRY BIEGELSEN Don't count BSX out yet. We expect BSX to continue to pursue GDT by potentially modifying or increas...
LARRY BIEGELSEN The transaction reflects our disciplined strategy of investing capital in core businesses where we c...
JAMIE DIMON We feel that by combining Red Hat's strengths in servers and workstation technology with Cygnus' exp...
ERIK TROAN With lingering concerns over Iran, Nigeria ... the market is correcting upwards because it is focusi...
VICTOR SHUM Larry has a proven track record as an effective financial executive with balanced experience in glob...
ANNE MULCAHY![]()
Larry has a proven track record as an effective financial executive with balanced experience in glob...
ANNE M. MULCAHY Share prices ended weaker. This is because of lingering concerns about a lack of active inflows of f...
HIDEO MIZUTANI![]()
In writing, I want to be remembered for telling good stories in beautiful and powerful language, usi...
KIM EDWARDS We are gratified that HP shareowners recognize the compelling strategic and economic benefits of the...
CARLY FIORINA![]()
What has always made IBM a fascinating and compelling place for me is the passion of the company, an...
GINNI ROMETTY We have a right to life, not on it.
DANIEL MELGAçO We don't completely understand the rationale for the magnitude of the downgrade.
JOE BURKE The catheter allows us to bathe the entire abdominal area with a high concentration of chemotherapy ...
DEBORAH ARMSTRONG The catheter allows us to bathe the entire abdominal area with a high concentration of chemotherapy ...
DR. DEBORAH ARMSTRONG One of our concerns is that EPA appears to be rushing full steam ahead with a revised standard befor...
DAN RIEDINGER Our position is that we're not opposed to biotechnology, although we had specific concerns with Roun...
MAUREEN FITZHENRY There's only one definitive offer for Guidant, and that's the one from Johnson & Johnson.
JEFF LEEBAW There's only one definitive offer for Guidant and that's the one from Johnson & Johnson.
JEFF LEEBAW It is a moderately fast-moving storm and will be out of here pretty much by Saturday, although there...
DAN ATKIN Although everything is smooth so far, all scientific and technological staff need to be cautious.
XINHUA NEWS AGENCY Although we have received many calls expressing concerns and anger about this incident, we have not ...
DAVID ADDISON The strength of the management team at Symantec gives me comfort in deciding to use this transition ...
GARY BLOOM Industry fundamentals remain robust and should drive internal growth, although near-term momentum ap...
MICHAEL RIETBROCK By terminating the acquisition, we now have available the $600 million for other strategic investmen...
LEONARD RIGGIO The potential universe of strategic buyers is quite limited. The people most likely to put in a bid ...
DAVID NADEL We were into October before we could say the Open didn't have some lingering presence.
DON PADGETT II Although history textbooks contain facts and information and historical fiction provides entertainme...
TERRI JOHNSON No rationale was provided for the change.
WAYNE OAKES Although less certain, screening indeed appears to be effective at lowering mortality.
DONALD BERRY We have a real proliferation problem that's taking place globally, ... This is only going to contrib...
BILL COHEN This investment bid is being made as part of the Boston Globe's long-term strategic plan to solidify...
JANET ROBINSON This investment bid is being made as part of the Boston Globe's long-term strategic plan to solidify...
JANET ROBINSON We have not had a strategic road map with clear expectations for the membership.
CHARLOTTE WESTERHAUS We at Guidant recognize that there is an increased appetite for information from our industry among ...
STEVE TRAGASH We continue to work with Guidant to understand and evaluate the impact of the various (recalls) that...
JEFFREY LEEBAW I'd like to think that the nature of the two teams - Boston being a championship team over the y...
OSCAR ROBERTSON![]()
The acquisition of the Marconi businesses has a compelling strategic logic and is a robust financial...
CARL-HENRIC SVANBERG The ramifications of workplace violence can have a lingering effect on the organization for generati...
ASA DON BROWN We strongly believe that our union with Guidant is the only one that can deliver and create lasting ...
WILLIAM WELDON Our October downgrade was based on concerns that are manifesting themselves now, although current co...
CHARLIE GLAVIN Interestingly, (Boston Scientific) only raised its bid by $1, signaling that price is but one factor...
JOANNE WUENSCH We needed playoff replacements for the Florida Pit Bulls and Gallup Talons. We chose the Ohio Aviato...
JOE NEWMAN It is a little bit of the season as many people are away for the summer combined with lingering conc...
FELIX BONI For the year overall, Canada -- although showing some slight decline -- appears to be having a stron...
DARREL RYCE Although there is a very large literature, still growing almost daily, on the Chinese calendar, its ...
JOSEPH NEEDHAM We're encouraged that Mr. Harper appears to have taken some of our concerns into account. If Mr. Har...
JACK LAYTON The price that I think you'd have to pay for St. Jude would be even more expensive than what Guidant...
THOMAS GUNDERSON Essentially, they (Guidant) are going to say ... yes there have been issues at Guidant, but do those...
FRANK AQUILA If the Guidant shareholders approve the acquisition on Jan. 31, we would close shortly thereafter.
JEFF LEEBAW![]()
IBM's long-standing mantra is 'Think.' What has always made IBM a fascinating and compel...
GINNI ROMETTY![]()
Although the trends are promising and reishi mushrooms exhibit a number of interesting medicinal pro...
PAUL STAMETS We are working on significant expansions and new opportunities, combining to make the outlook for fu...
FRANK CHAPMAN Hype does not last long. When you think about the rationale behind the work we have done for two and...
DUANE KNAPP It's all about building a base in professional market, ... We have to have a compelling product and ...
WAYNE INOUYE We have to be more strategic in the distribution,
DAVID SATCHER If Boston Scientific is to come back, they will have to come back north of US$75 to keep this alive....
KEAY NAKAE Over the last several months, we have thoroughly weighed strategic alternatives for our Northern Dep...
BRAD MARTIN They have some concerns. We have some concerns. We came to an agreement and that's between their del...
ENRIQUE CRUZ The celebratory spirit in Boston is unbelievable, ... But Boston being Boston, the fans aren't reall...
CARLTON FISK The only time I'm ever close to Larry is when we start the race and then this morning I kept in sigh...
JACK BURTON We have the attitude that if it is strategic, that's great, but if it's a financial bath, then it's ...
JAMES HOLDEN
JOANNE WUENSCH We suspect the new Boston Scientific offer was developed with input from the Guidant board, so it's ...
LARRY BIEGELSEN If J&J is not willing to up their bid, I think Guidant will be going to Boston Scientific.
DEBBIE WANG At this point, we do not know if J&J is simply trying to force Boston Scientific to go higher, or if...
BOB HOPKINS Today's outcome is a tremendous victory and a major milestone within the merger process, ... It is c...
KEN THOMPSON I would try to settle all the outstanding liability claims at this point in time, so that it doesn't...
ALLEN MICHEL I don't believe these things are going to matter for Boston Scientific. This is a strategic deal for...
JAN WALD This is disappointing, as we believe the logic for combining the two businesses is compelling.
LORNA TILBIAN In our opinion, the strategic rationale is sound and price paid is lower than what we would have ant...
MORGAN STANLEY It's very clear Boston Scientific is not making this acquisition for what this company can do in 200...
FRANK AQUILA Q4 is behind us, and what the Boston Scientific investment thesis is now is the future, and particul...
THOMAS GUNDERSON Lingering concerns about an inventory correction simply have not been borne out.
DANIEL HEYLER We have brought a lot of companies into the Boston Scientific family and we have never been more con...
PAUL DONOVAN I think Boston Scientific and ANSI have the better technology now, especially with the rechargeable.
JEFF JONAS I think Boston Scientific and ANSI have the better technology now, especially with the rechargeable,
JEFF JONAS We see no compelling scientific reason to re-create the virulent virus.
EDWARD HAMMOND We believe the transaction and the strategic rationale for this combination are in the best interest...
JAMES CORNELIUS If the deals went to shareholders today, we believe Boston Scientific would prevail.
MARK LANDY We feel that by combining Red Hat's strengths in servers and workstation technology with Cygnus' exp...
ERIK TROAN
What the Commission is seeking cuts the heart out of the strategic rationale of our deal, JACK WELCH Myths about the dire effects of genetically modified foods on health and the environment abound, but...
NINA FEDOROFF Underneath the covers I believe that Abbott wants to be a device player and for the first time they ...
RYAN RAUCH It's a slam-dunk for Boston Scientific, and I think there are implications for the rest of the indus...
DHULSINI DE ZOYSA I don't see material upside or downside (for Boston Scientific shares) for the next 12 months.
MARK LANDY We see a very compelling strategic fit and see our combined companies strongly positioned to compete...
LARRY GLASSCOCK We doubt this show is over, and in the end we expect that Boston Scientific will increase its bid.
JOANNE WUENSCH I like to open for a band as it brings on sort of a challenge and it makes things more interesting. ...
KELLY JONES We ask that you declare any subsequent offer with improved terms from Boston Scientific as superior.
IVAN KRSTICEVIC One of the most compelling findings is that AAV-2 appears to have no pathologic effects on healthy c...
CRAIG MEYERS FEMA is aware of local concerns where sites are proposed, and balances those concerns with its urgen...
SCOTT WELLS We believe that Boston Scientific can raise its offer to $78 a share and still maintain an investmen...
LARRY BIEGELSEN We believe this compelling valuation offsets very real concerns about management's ability to develo...
CHRISTOPHER DIXON Boston Scientific wants as many shots on goal as they can get.
DANIEL OWCZARSKI There are compelling advantages to combining these operations. It allows us to leverage the strength...
GARY RODKIN There is no compelling reason today for these businesses to remain together. Almost every strategic ...
BRUCE WASSERSTEIN Despite the efficacy advantage, CAIV-T will have to overcome its premium pricing and lingering safet...
JAMES REDDOCH Boston Scientific still has much 'wood to chop' regarding the recovery of the company's cardiac rhyt...
GLENN REICIN Combining premier aviation choices and luxury destinations is a win-win for both of our companies. W...
KEN AUSTIN In our view, Abbott is the clear winner in this deal.
LARRY BIEGELSEN Don't count BSX out yet. We expect BSX to continue to pursue GDT by potentially modifying or increas...
LARRY BIEGELSEN The transaction reflects our disciplined strategy of investing capital in core businesses where we c...
JAMIE DIMON We feel that by combining Red Hat's strengths in servers and workstation technology with Cygnus' exp...
ERIK TROAN With lingering concerns over Iran, Nigeria ... the market is correcting upwards because it is focusi...
VICTOR SHUM Larry has a proven track record as an effective financial executive with balanced experience in glob...
ANNE MULCAHY
Larry has a proven track record as an effective financial executive with balanced experience in glob... ANNE M. MULCAHY Share prices ended weaker. This is because of lingering concerns about a lack of active inflows of f...
HIDEO MIZUTANI
In writing, I want to be remembered for telling good stories in beautiful and powerful language, usi... KIM EDWARDS We are gratified that HP shareowners recognize the compelling strategic and economic benefits of the...
CARLY FIORINA
What has always made IBM a fascinating and compelling place for me is the passion of the company, an... GINNI ROMETTY We have a right to life, not on it.
DANIEL MELGAçO We don't completely understand the rationale for the magnitude of the downgrade.
JOE BURKE The catheter allows us to bathe the entire abdominal area with a high concentration of chemotherapy ...
DEBORAH ARMSTRONG The catheter allows us to bathe the entire abdominal area with a high concentration of chemotherapy ...
DR. DEBORAH ARMSTRONG One of our concerns is that EPA appears to be rushing full steam ahead with a revised standard befor...
DAN RIEDINGER Our position is that we're not opposed to biotechnology, although we had specific concerns with Roun...
MAUREEN FITZHENRY There's only one definitive offer for Guidant, and that's the one from Johnson & Johnson.
JEFF LEEBAW There's only one definitive offer for Guidant and that's the one from Johnson & Johnson.
JEFF LEEBAW It is a moderately fast-moving storm and will be out of here pretty much by Saturday, although there...
DAN ATKIN Although everything is smooth so far, all scientific and technological staff need to be cautious.
XINHUA NEWS AGENCY Although we have received many calls expressing concerns and anger about this incident, we have not ...
DAVID ADDISON The strength of the management team at Symantec gives me comfort in deciding to use this transition ...
GARY BLOOM Industry fundamentals remain robust and should drive internal growth, although near-term momentum ap...
MICHAEL RIETBROCK By terminating the acquisition, we now have available the $600 million for other strategic investmen...
LEONARD RIGGIO The potential universe of strategic buyers is quite limited. The people most likely to put in a bid ...
DAVID NADEL We were into October before we could say the Open didn't have some lingering presence.
DON PADGETT II Although history textbooks contain facts and information and historical fiction provides entertainme...
TERRI JOHNSON No rationale was provided for the change.
WAYNE OAKES Although less certain, screening indeed appears to be effective at lowering mortality.
DONALD BERRY We have a real proliferation problem that's taking place globally, ... This is only going to contrib...
BILL COHEN This investment bid is being made as part of the Boston Globe's long-term strategic plan to solidify...
JANET ROBINSON This investment bid is being made as part of the Boston Globe's long-term strategic plan to solidify...
JANET ROBINSON We have not had a strategic road map with clear expectations for the membership.
CHARLOTTE WESTERHAUS We at Guidant recognize that there is an increased appetite for information from our industry among ...
STEVE TRAGASH We continue to work with Guidant to understand and evaluate the impact of the various (recalls) that...
JEFFREY LEEBAW I'd like to think that the nature of the two teams - Boston being a championship team over the y...
OSCAR ROBERTSON
The acquisition of the Marconi businesses has a compelling strategic logic and is a robust financial... CARL-HENRIC SVANBERG The ramifications of workplace violence can have a lingering effect on the organization for generati...
ASA DON BROWN We strongly believe that our union with Guidant is the only one that can deliver and create lasting ...
WILLIAM WELDON Our October downgrade was based on concerns that are manifesting themselves now, although current co...
CHARLIE GLAVIN Interestingly, (Boston Scientific) only raised its bid by $1, signaling that price is but one factor...
JOANNE WUENSCH We needed playoff replacements for the Florida Pit Bulls and Gallup Talons. We chose the Ohio Aviato...
JOE NEWMAN It is a little bit of the season as many people are away for the summer combined with lingering conc...
FELIX BONI For the year overall, Canada -- although showing some slight decline -- appears to be having a stron...
DARREL RYCE Although there is a very large literature, still growing almost daily, on the Chinese calendar, its ...
JOSEPH NEEDHAM We're encouraged that Mr. Harper appears to have taken some of our concerns into account. If Mr. Har...
JACK LAYTON The price that I think you'd have to pay for St. Jude would be even more expensive than what Guidant...
THOMAS GUNDERSON Essentially, they (Guidant) are going to say ... yes there have been issues at Guidant, but do those...
FRANK AQUILA If the Guidant shareholders approve the acquisition on Jan. 31, we would close shortly thereafter.
JEFF LEEBAW
IBM's long-standing mantra is 'Think.' What has always made IBM a fascinating and compel... GINNI ROMETTY
Although the trends are promising and reishi mushrooms exhibit a number of interesting medicinal pro... PAUL STAMETS We are working on significant expansions and new opportunities, combining to make the outlook for fu...
FRANK CHAPMAN Hype does not last long. When you think about the rationale behind the work we have done for two and...
DUANE KNAPP It's all about building a base in professional market, ... We have to have a compelling product and ...
WAYNE INOUYE We have to be more strategic in the distribution,
DAVID SATCHER If Boston Scientific is to come back, they will have to come back north of US$75 to keep this alive....
KEAY NAKAE Over the last several months, we have thoroughly weighed strategic alternatives for our Northern Dep...
BRAD MARTIN They have some concerns. We have some concerns. We came to an agreement and that's between their del...
ENRIQUE CRUZ The celebratory spirit in Boston is unbelievable, ... But Boston being Boston, the fans aren't reall...
CARLTON FISK The only time I'm ever close to Larry is when we start the race and then this morning I kept in sigh...
JACK BURTON We have the attitude that if it is strategic, that's great, but if it's a financial bath, then it's ...
JAMES HOLDEN
I gave a funny speech at my wife's birthday party, and I'm thinking, 'Hey, I've stil... 
I had a wonderful childhood, which is tough because it's hard to adjust to a miserable adulthood... 
The human species really could have faced global thermonuclear war. During seventy years of Cold War... 
The three chief virtues of a programmer are: Laziness, Impatience and Hubris. 
Most jokes state a bitter truth. 
My grandfather was an autoworker, and I have a weapon he manufactured to protect himself from the co... 
I would consider myself more a passionate centrist. 
Sometimes I'd say what's bad for the country is good for my business, unfortunately. 
I'll stop talking about race when people stop being racist. 
Some of modern engineering is necessary to good art. But I think of myself is a cultural artist. 
I'm just paid to do whatever I want to do. Some of the time it's development, and some of th... 
I like going to Burning Man, for example. An environment where people can try new things. I think as... 
The idea that everyone should slavishly work so they do something inefficiently so they keep their j... 
I do not believe they've run out of surprises. 
SF isn't a genre; SF is the matrix in which genres are embedded, and because the SF field is nev... 
Members of the Academy are mostly urban people. We are an urban nation. We are not a rural nation. I... 
Americans don't want cowboys to be gay. 
If we know anything about man, it's that he's not pacific. The temptation to butcher anyone ... 
I forgot that San Francisco is not an angry city like New York. Gays have gotten what they wanted th... 
We're still leaderless. We still don't have strong organizations that are fighting for us; t... 
Most of the Michelle Bachmanns and Mitt Romneys who say such terrible things about us actually is a ... 